Skip to content
OpenCapital
Get started

Intuitive Surgical ISRG Cash & Equivalents

Cash & Equivalents at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$20.42B+9.9%
Stryker logo
StrykerSYK
$2.88B+24.1%
Microbot Medical logo
Microbot MedicalMBOT
$3.66M+13.7%
Novanta logo
NovantaNOVT
$388.8M+267%
Pulmonx Corporation logo
Pulmonx CorporationLUNG
$61.03M-2.4%
PROCEPT BioRobotics Corporation logo
PROCEPT BioRobotics CorporationPRCT
$12.23M-96.2%

Other financials

Income statement

See full
Revenue$2.9B+18.5%
Gross profit$2.0B+21.2%
Operating income$971.9M+30.7%
Net income$818.1M+24.3%
EPS (diluted)$2.29+26.5%

Balance sheet

See full
Total debt$170.9M+17.1%
Total equity$18.2B+1.8%
Total assets$20.9B+3.5%

Cash flow

See full
Operating cash flow$1.1B+48.3%
CapEx$112.6M-27.5%
Free cash flow$948.4M+69.3%

Valuation

See full
Market cap$120.92B-31.7%
P/E38.5×-29.4×
P/S11×-8.4×

Profitability

See full
Gross margin66.7%+0.1pp
Operating margin31.3%+2.5pp
Net margin28.4%-0.1pp
FCF margin29.2%+7.4pp

Returns & leverage

See full
Return on equity17.4%+1.4pp
Debt / equity0×0.0×
Current ratio5×-0.2×

Where this comes from

Reported directly by Intuitive Surgical in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Intuitive Surgical’s 10-Q, filed July 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intuitive Surgical's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Intuitive Surgical's cash & equivalents?
Intuitive Surgical (ISRG) reported cash & equivalents of $2.81B in Q2 2026.
How has Intuitive Surgical's cash & equivalents changed year-over-year?
Intuitive Surgical's cash & equivalents decreased by 18.6% year-over-year, from $3.45B to $2.81B.
What is the long-term trend for Intuitive Surgical's cash & equivalents?
Over 5 years (2020 to 2025), Intuitive Surgical's cash & equivalents has grown at a 15.8% compound annual growth rate (CAGR), from $1.64B to $3.41B.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.